Successful use of infliximab following a failed course of etanercept in a pediatric patient

Dermatology Online Journal

Volumn 11, Issue 3, 2005, Pages

  Farnsworth, Neil N ^a   George, Saira J ^a   Hsu, Sylvia ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPSORIASIS AGENT; ETANERCEPT; INFLIXIMAB; PIMECROLIMUS; STEROID; TACROLIMUS; TAZOROTENE; TRIAMCINOLONE; UNCLASSIFIED DRUG;

ACNE; ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; HUMAN; HYPERTENSION; MALE; OBESITY; PSORIASIS; TREATMENT FAILURE;

EID: 29844443537     PISSN: 10872108     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Lebwohl M. Psoriasis. Lancet. 2003 Apr 5;361(9364):1197-204.
2. Gottlieb AB. Infliximab for psoriasis. J Am Acad Dermatol. 2003 Aug;49(2 Suppl):S112-7.
3. Serrano MS, Schmidt-Sommerfeld E, Kilbaugh TJ, Brown RF, Udall JN Jr, Mannick EE. Use of infliximab in pediatric patients with inflammatory bowel disease. Ann Pharmacother. 2001 Jul-Aug;35(7-8):823-8.
4. Lewkowicz D, Gottlieb AB. Pediatric psoriasis and psoriatic arthritis. Dermatol Ther. 2004;17(5):364-75.
5. Menter MA, Cush JM. Successful treatment of pediatric psoriasis with infliximab. Pediatr Dermatol. 2004 Jan-Feb;21(1):87-8.